Centiva Capital, LP Cytokinetics Inc Put Options Transaction History

Centiva Capital, LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $128,050 - $150,400	-2,500 Reduced 25.0%	7,500 $396,000
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $478,600 - $750,500	-10,000 Reduced 50.0%	10,000 $541,000
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $1.15 Million - $1.96 Million	18,100 Added 952.63%	20,000 $1.4 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $45,696 - $141,933	-1,700 Reduced 47.22%	1,900 $158,000
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $106,056 - $131,796	3,600 New	3,600 $106,000

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.57B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.